Liboce Trio 1mg/500mg/0.2mg Tablet SR
Marketer
Syntonic Lifesciences
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Liboce Trio 1mg/500mg/0.2mg Tablet SR
Tricorbin 1mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, helping regulate blood glucose control. Tricorbin 1mg/500mg/0.2mg Extended-Release Tablets should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood glucose monitoring. Continued use is crucial, even with well-controlled blood sugar, as discontinuation without medical consultation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan incorporating a healthy diet, regular physical activity, and weight management, as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Recognizing these symptoms and carrying a readily available fast-acting glucose source (e.g., sugary snacks or juice) is essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Consult your doctor before using this medication if you are pregnant or breastfeeding. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Liboce Trio 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Liboce Trio 1mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Liboce Trio 1mg/500mg/0.2mg Tablet SR. Ingest the tablet whole; do not chew, crush, or divide it. Administer on an empty stomach.
Common Side effects of Liboce Trio 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Liboce Trio 1mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Liboce Trio 1mg/500mg/0.2mg Tablet SR. Ingest the tablet whole; do not crush, chew, or divide it. Administer on an empty stomach.
How Liboce Trio 1mg/500mg/0.2mg Tablet SR works:
Liboce Trio extended-release tablets (1mg/500mg/0.2mg) contain a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Liboce Trio 1mg/500mg/0.2mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Liboce Trio 1mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against these risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Liboce Trio 1mg/500mg/0.2mg tablet is likely not safe for breastfeeding mothers. Preliminary human evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney disease should likely avoid Liboce Trio 1mg/500mg/0.2mg Tablet SR, as its use may be unsafe. Medical advice is recommended. Furthermore, this medication is not advised for individuals with severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Liboce Trio 1mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is recommended. For those with mild to moderate liver disease, initiation with a low dose is typical; however, the medication is contraindicated in cases of severe hepatic dysfunction.
What if you forget to take Liboce Trio 1mg/500mg/0.2mg Tablet SR :
Should you forget a Liboce Trio 1mg/500mg/0.2mg Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Liboce Trio 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
3,018 People bought this recently